Estradiol promotes growth and angiogenesis in polyoma middle T transgenic mouse mammary tumor explants
Family history of breast and ovarian cancer and the risk of breast carcinoma in situ*
Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo*
The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study
A novel aspartic protease gene, ALP56, is up-regulated in human breast cancer independently from the cathepsin D gene
Increased expression of BRCA1 mRNA predicts favorable response to anthracycline-containing chemotherapy in breast cancers
Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI
Tamoxifen and the farnesyl transferase inhibitor FTI-277 synergize to inhibit growth in estrogen receptor-positive breast tumor cell lines
Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation
Retrospective analysis of breast cancer among young African American females
Reproductive factors, glutathione S-transferase M1 and T1 genetic polymorphism and breast cancer risk
Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy
Estrogen receptors and distinct patterns of breast cancer relapse*
The modified firefly luciferase reporter gene (luc+) but not Renilla luciferase is induced by all-trans retinoic acid in MCF-7 breast cancer cells
Consensus Statement: Expedition Inspiration Fund for Breast Cancer Research Meeting 2002
Mutational analysis of estrogen receptor-beta gene in human breast cancers